Multicenter Trial Evaluating the Safety and Efficacy of Autologous Volar Fibroblast Injection Into the Terminal Limb of Amputees.

NCT04839497 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Amputation

Interventions

COMBINATION_PRODUCT: Autologous Volar Fibroblast Injection into the Terminal Limb of Amputees

Sponsor

Major Extremity Trauma Research Consortium

Collaborators

[object Object]